CommonQuant
CommonQuant.ai Research
AI-generated trading idea · BULLISH · CRDO

Credo sold off even though the biggest news in its end market — a $15 billion credit facility for Anthropic — shows AI players are still securing huge war chests to build data centers. When a stock drops while its customers' funding news is strongly posit

Credo sold off even though the biggest news in its end market — a $15 billion credit facility for Anthropic — shows AI players are still securing huge war chests to build data centers. When a stock drops while its customers' funding news is strongly positive, the weakness is often short-term profit-taking rather than a broken thesis. Buying AI connectivity names after a sharp dip, while capex money keeps flowing, has historically offered a favorable rebound setup.

Idea

Credo sold off even though the biggest news in its end market — a $15 billion credit facility for Anthropic — shows AI players are still securing huge war chests to build data centers. When a stock drops while its customers' funding news is strongly positive, the weakness is often short-term profit-taking rather than a broken thesis. Buying AI connectivity names after a sharp dip, while capex money keeps flowing, has historically offered a favorable rebound setup.

Advanced Analysis — institutional-depth research report

Credo: the fundamentals argue for patience, and the chart hasn't earned a trade yet

**Verdict: strong business, no trigger — wait.** Credo's fundamentals genuinely support the idea's claim that demand is intact: fiscal 2026 revenue hit $1.34B, up roughly 206% year over year, with net margin at 35.4%, free cash flow of $407.0M, $1.16B in cash and no long-term debt, and CEO pay at a modest $1.79M for fiscal 2026. The strongest point against is that the 'profit-taking, not a broken thesis' framing is an assumption, not a fact — the latest quarter's revenue of $437.0M, net income of $169.1M and free cash flow of $177.5M all declined against the prior comparative periods, and shares outstanding have grown about 25% since fiscal 2023, with no dividend paid (none on file as of September 5, 2026) to cushion the wait. Meanwhile the trade itself is nowhere near ready: the stock closed at $170.57 with the 14-day RSI at 25.4, price 26% below the 20-day EMA at $215.37, and the entry rules never fired across 495 evaluated daily bars over 24 months — a watch-list setup, not an active signal. The ownership filing covering June 30, 2026 shows only 3 holders with about 797,000 shares, a delayed and thin read, so it adds nothing either way. What would flip the verdict: a daily close back above $215.37 with RSI recovering above 40, or a next quarterly print showing revenue re-accelerating — until then, waiting is the right call. **Conviction breakdown:** thesis support is solid on the growth-and-balance-sheet evidence (68), fundamentals trend remains positive despite the latest-quarter declines (65), risk quality is decent with a defined 2.5% stop and roughly 2:1 reward-to-risk but no dividend cushion (60), trade readiness is weak because no robust parameter setup was established (40), and trigger proximity is very low with all entry conditions far from firing (20).

Conviction score breakdownComposite score computed by the server from the applicable evidence-tier dimensions.
MeasureValue
Thesis support68/100
Trade readiness40/100
Risk quality60/100
Trigger proximity20/100
Fundamentals trend65/100
Score51/100
Composite Score51/100
Evidence Tierrules_not_triggered
Decision scenariosBull, base, and bear cases synthesized from the cited evidence tier. Likelihoods are rounded evidence-weighted judgments, not statistically calibrated forecasts.
MeasureValue
Evidence Tierrules_not_triggered

Trade now

CRDO closed at $170.57, and the setup is still in wait mode rather than buy mode. The strategy's entry needs four things at once on the daily chart: a close crossing above the 20-day EMA (now $215.37), the 14-day RSI crossing back above 40, RSI staying below 45, and price above that EMA. RSI is 25.4 — it already meets the below-45 condition but sits 14.6 points below the momentum trigger — and price would need to rise roughly 26% to reach the EMA. None of the crossing conditions is close to firing, so today's action is to wait, not to buy the dip by hand. If an entry does trigger, the risk is tightly defined. The hard stop is a close below the second-ranked support at $160, with a position-level stop at a 2.5% loss, and profit-taking at a 5.0% gain or at the top-ranked resistance of $171.36 (plus an RSI exit above 70 or a 60-day time exit). With a 2.5% stop against a 5.0% target, the effective reward-to-risk is about 2:1, sized so any single loss costs no more than 2.5% of the account, and no more than 25% of capital goes into the name. Concretely, waiting means: no position until CRDO closes back above $215.37 with RSI back above 40 but still below 45. Given price is 44.8 points below the EMA today, that is a material recovery, not an imminent trigger — which is exactly what the rule evaluation shows. One factual scope note: no robust parameter setup was established because the frozen rules could not be evaluated across the windows, so the published thresholds above are the ones you watch. The tension to hold in mind: the idea argues the sell-off is profit-taking against a healthy capex backdrop (the $15 billion Anthropic credit facility, per the idea's thesis), but SEC data for the period ended April 30, 2026 shows revenue of $437.0M, down 67.3% from $1.34B, with net income down 64.2% to $169.1M and free cash flow down 56.4% to $177.5M. Gross margin was essentially flat at 68.2%, so the rules-based entry discipline matters more than usual here — let the trigger confirm the rebound rather than front-running it.

CRDO price and trigger mapUses the idea timeframe and keeps price levels on the price axis.
MeasureValue
TickerCRDO
Timeframe1d

Demand Money Is Still Flowing — and the Fundamentals Back It Up

The idea's core claim…

CRDO Free cash flowFree cash flow trend from CommonQuant fundamentals/XBRL data; +483.1% from first to latest point.
MeasureValue
2023-04-30$-46328000
2024-04-30$17085000
2025-04-30$29022000
2025-04-30$54167000
2025-07-31$51347000
2025-10-31$38477000
2026-01-31$139703000
2026-04-30$406996000
2026-04-30$177469000
Latest Value$177469000
Change Pct$483.07071317561736
TickerCRDO
Timeframereported periods
CRDO Operating marginOperating margin trend from CommonQuant fundamentals/XBRL data; +448.9% from first to latest point.
MeasureValue
2023-04-30-0.10221831330010749%
2024-04-30-0.19204021350468983%
2025-04-300.08499570717188484%
2025-04-300.20385825613880312%
2025-07-310.2722952921452074%
2025-10-310.2939853074503688%
2026-01-310.36761078297445776%
2026-04-300.33330811704750746%
2026-04-300.356622265751036%
Latest Value0.356622265751036%
Change Pct448.8829488939151%
TickerCRDO
Timeframereported periods

Scores

  • Conviction score breakdown: 51
  • Thesis support: 68
  • Trade readiness: 40
  • Risk quality: 60
  • Trigger proximity: 20
  • Fundamentals trend: 65

Watch items

  • CRDO — RSI (14) crossing above 40
  • CRDO — Daily close vs 20-day EMA
  • CRDO — Daily close vs second-ranked support
  • CRDO — Quarterly revenue trend (SEC XBRL)
  • CRDO — Institutional shares held (13F)
Unlock full analysis — 100 credits

Key details

CRDO1d#canonical-demand#cluster-version:1#direction:bullish#entity-kind:instrument#entity:CRDO#horizon:unspecified#intent:research#symbol:CRDO

Community

1
Upvotes
0
Views
0
Copies
0
Cosigns

News sources

Related